EPISODE · Apr 23, 2025 · 52 MIN
Hormone Receptor-Positive Metastatic Breast Cancer — An Interview with Dr Adam M Brufsky on the Impact of Biomarkers and Existing Comorbidities on the Selection of First-Line Therapy
from Oncology Today with Dr Neil Love
Dr Adam M Brufsky from the University of Pittsburgh discusses first-line treatment selection for patients with HR-positive metastatic breast cancer and preexisting medical conditions. CME information and select publications here.
Embed this episode
Ready to play
Hormone Receptor-Positive Metastatic Breast Cancer — An Interview with Dr Adam M Brufsky on the Impact of Biomarkers and Existing Comorbidities on the Selection of First-Line Therapy
0:00
52:52
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Oncology Today with Dr Neil Love?
This episode is 52 minutes long.
When was this Oncology Today with Dr Neil Love episode published?
This episode was published on April 23, 2025.
Can I download this Oncology Today with Dr Neil Love episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!